Day One Biopharmaceuticals Inc (DAWN)
17.17
-0.40
(-2.28%)
USD |
NASDAQ |
May 03, 16:00
17.15
-0.02
(-0.12%)
After-Hours: 20:00
Day One Biopharmaceuticals 1 Year Total Returns (Daily): 20.83% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 20.83% |
May 02, 2024 | 25.68% |
May 01, 2024 | 22.25% |
April 30, 2024 | 37.90% |
April 29, 2024 | 32.90% |
April 26, 2024 | 17.48% |
April 25, 2024 | 12.52% |
April 24, 2024 | 10.80% |
April 23, 2024 | 21.46% |
April 22, 2024 | 12.26% |
April 19, 2024 | 18.07% |
April 18, 2024 | 24.90% |
April 17, 2024 | 16.38% |
April 16, 2024 | 18.40% |
April 15, 2024 | 12.24% |
April 12, 2024 | 10.51% |
April 11, 2024 | 10.27% |
April 10, 2024 | 13.46% |
April 09, 2024 | 11.65% |
April 08, 2024 | 8.39% |
April 05, 2024 | 15.73% |
April 04, 2024 | 12.52% |
April 03, 2024 | 18.90% |
April 02, 2024 | 18.47% |
April 01, 2024 | 20.87% |
Date | Value |
---|---|
March 28, 2024 | 29.16% |
March 27, 2024 | 19.62% |
March 26, 2024 | 1.31% |
March 25, 2024 | -1.96% |
March 22, 2024 | -6.83% |
March 21, 2024 | -15.96% |
March 20, 2024 | -20.05% |
March 19, 2024 | -23.63% |
March 18, 2024 | -22.91% |
March 15, 2024 | -22.92% |
March 14, 2024 | -25.00% |
March 13, 2024 | -20.50% |
March 12, 2024 | -17.94% |
March 11, 2024 | -15.60% |
March 08, 2024 | -19.59% |
March 07, 2024 | -21.34% |
March 06, 2024 | -14.05% |
March 05, 2024 | -10.99% |
March 04, 2024 | -9.87% |
March 01, 2024 | -6.03% |
February 29, 2024 | -9.17% |
February 28, 2024 | -8.63% |
February 27, 2024 | -5.23% |
February 26, 2024 | -13.01% |
February 23, 2024 | -18.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-77.91%
Minimum
May 27 2022
116.9%
Maximum
May 26 2023
-3.81%
Average
-14.34%
Median
1 Year Total Returns (Daily) Benchmarks
Revolution Medicines Inc | 68.69% |
Zentalis Pharmaceuticals Inc | -45.10% |
Perspective Therapeutics Inc | 196.0% |
Electromed Inc | 78.40% |
Xtant Medical Holdings Inc | 41.62% |